Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07631468 · ClinicalTrials.gov registry record

PROspect Registry :Post Market Clinical Follow-up Study

A clinical trial, sponsored by Stryker Endoscopy.

Not yet
Registry status
5,000
Enrollment target

NCT07631468: Clinical Trial study, sponsored by Stryker Endoscopy.

NCT07631468 is a clinical trial that has not yet begun recruiting, run by Stryker Endoscopy. The registered enrollment target is 5,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07631468 has not yet begun recruiting, sponsored by Stryker Endoscopy.

NOT YET RECRUITING
Registry status
5,000 participants
Enrollment target

Study Summary

Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

Primary Outcome

(proportion of MOLLI markers that are detected intraoperatively)

Interventions

  • DEVICE Standard of care treatment

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2026-06-01
Est. Completion 2031-12-01
Stryker Endoscopy

4 total trials

What is known before NCT07631468 opens enrollment

NCT07631468 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Standard of care treatment is the first listed.

NCT07631468 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07631468 about?

NCT07631468 is a clinical study titled "PROspect Registry :Post Market Clinical Follow-up Study". Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

What is the current status of trial NCT07631468?

This trial is currently not yet recruiting. The enrollment target is 5,000 participants. The study started on 2026-06-01. Estimated completion is 2031-12-01.

What interventions are being tested in trial NCT07631468?

The interventions under investigation include: Standard of care treatment (DEVICE).

Who is sponsoring clinical trial NCT07631468?

This trial is sponsored by Stryker Endoscopy, which has 4 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07631468, the US trial registry maintained by the National Library of Medicine. NCT07631468 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.